VANDA PHARMACEUTICALS INC. Debt Securities, Available-for-sale, Amortized Cost
VANDA PHARMACEUTICALS INC. (VNDA) had Debt Securities, Available-for-sale, Amortized Cost of $384.47 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2022-08-04
- 2022-06-30: Debt Securities, Available-for-sale, Amortized Cost $384.47M.
- 2022-03-31: Debt Securities, Available-for-sale, Amortized Cost $369.99M.
- 2021-12-31: Debt Securities, Available-for-sale, Amortized Cost $381.01M.
- 2021-09-30: Debt Securities, Available-for-sale, Amortized Cost $355.34M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2022-06-30 | $384.47M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $369.99M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $381.01M 10-Q · filed 2022-08-04 |
| 2021-09-30 | $355.34M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $339.18M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $305.82M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $306.50M 10-K · filed 2022-02-24 |
| 2020-09-30 | $291.14M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $243.78M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $266.75M 10-K · filed 2021-02-11 |
| 2019-09-30 | $260.12M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $245.76M 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |